Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HAVN Life Sciences Inc. Board/Management Information 2020

Oct 16, 2020

47913_rns_2020-10-16_bb37939b-0db6-410e-94c3-e2544512e5f1.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

FORM 51-102F3 Material Change Report

ITEM 1 Name and Address of Company

HAVN Life Sciences Inc. (the “ Company ”) 2200 – 885 West Georgia Street Vancouver, BC V6C 3E8

ITEM 2 Date of Material Change

October 5, 2020

ITEM 3 News Release

News release announcing the material change was disseminated on October 5, 2020 and was subsequently filed on SEDAR.

ITEM 4 Summary of Material Changes

On October 5, 2020, the Company announced the departure of Mr. Robert Nygren as Co-head of Corporate Development and as a director of the Company.

ITEM 5

Full Description of Material Change

On October 5, 2020, the Company announced the departure of Mr. Robert Nygren as Co-head of Corporate Development and as a director of the Company.

ITEM 6 Reliance on Subsection 7.1(2) of National Instrument 51-102

Not applicable.

ITEM 7 Omitted Information

No information has been omitted on the basis that it is confidential information.

ITEM 8 Executive Officer

For further information, please contact Susan Chapelle or Tim Moore, Co-Chief Executive Officers of the Company, at 604-359-0060.

ITEM 9 Date of Report

October 15, 2020